Indications and Safety Profile of Musculoskeletal Contrast-Enhanced Ultrasound with SonoVue®
- Conditions
- PSEUDARTHROSIS SUPRASPINATUS TENDON RUPTURE
- Registration Number
- DRKS00017406
- Lead Sponsor
- Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
Data of study patients, who underwent musculoskeletal CEUS examinations with SonoVue® between 2012 and 2019, were included.
Exclusion Criteria
Exclusion criteria for the utilization of CEUS were a history of recent myocardial infarction, an intracardial right-left shunt, uncontrollable fluctuations of blood pressure, severe respiratory disease (pulmonary arterial hypertension (PAH), severe acute respiratory syndrome (SARS), during pregnancy and while breast-feeding (missing studies, no evidence) or any known allergic reaction to SonoVue® as well as other similar contrast agents. Further exclusion criteria were an age younger than 18 years and the lack of the patients’ informed consent.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse Events of every application of SonoVue®
- Secondary Outcome Measures
Name Time Method Incidence of severe adverse Events of every application of SonoVue®